Please join Dr. Vipul Jairath (CIBRN Chair) for WEBINAR 1 of 2018 to be held May 14 at 8pm EST, focused on the recent article in The Lancet Gastroenterology & Hepatology, by Strik et al:
Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial
Webinar access info was sent to you by email on May 4.
This year, acting on the suggestions from the 2017 yearend survey, we’re replacing ‘structured questions’ as catalysts for discussion in favour of 4 virtual reviews (VR) of articles of interest. It is hoped that by anchoring discussions in the context of important articles, that the exchange may be more organic in nature and ideally produce complementary veins of conversation.
Prior to the webinar, you are invited to read the article chosen as the subject of the first virtual review. See link above.
The webinar will be recorded and archived for future viewing by the CIBRN community.
If you have any comments or questions, please contact me at your convenience.